Congenital heart disease affects 0.8% of all live-born infants. Some of the malformed hearts can at best be palliated by conventional surgical or catheter interventions from the start. Others fail slowly from chronic overloading. Patients with congenital heart disease have been among the first transplant recipients since 1967. Primary therapy with infant heart transplant is a convincing concept from an immunological perspective but large-scale implementation is limited by donor organ shortages. Another growing area is rescue therapy for older patients with end-stage heart failure after palliative procedures, particularly those with single-ventricle hearts, systemic right ventricles, and associated arrhythmias.
Transplantation as a primary treatment for hypoplastic left heart syndrome: intermediate-term results
Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome
Orthotopic heart transplantation for congenital heart disease: an alternative for high-risk fontan candidates?
Altered ventricular mechanics in cardiac allografts: a tissue Doppler study in 30 children without prior rejection events
Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices
Heart-lung transplantation in a patient with large aortopulmonary collaterals by means of an extended approach
Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Long-term outcome of palliation with internal pulmonary artery bands after primary heart transplantation for hypoplastic left heart syndrome
The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease
Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Heart Transplantation Report-2009
Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients
Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?
Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible
Use of diagnostic information submitted to the United Kingdom Central Cardiac Audit Database: development of categorisation and allocation algorithms
In vitro performance analysis of a novel pulsatile diagonal pump in a simulated pediatric mechanical circulatory support system
Impact of Pulsatile Flow Settings on Hemodynamic Energy Levels Using the Novel Diagonal Medos DP3 Pump in a Simulated Pediatric Extracorporeal Life Support System
Heart Transplantation for Pediatric and Congenital Cardiac Disease: A Comparison of Two Eras over 23 Years and 188 Transplants at a Single Institution.
Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.
Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.